![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1301165
¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : Á¦Ç°º°(¿Â¿/³Ã°¨ Á¦Ç°, Ű³×½Ã¿Ã·ÎÁö Å×ÀÌÇÁ, TENS ±â±â, Àû»ö±¤¼±¿ä¹ý/Àû¿Ü¼±¿ä¹ý Á¦Ç°), À¯Åë ä³Îº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)U.S. External Analgesics Market Size, Share & Trends Analysis Report By Product (Hot/Cold Products, Kinesiology Tape, TENS Devices, Red Light Therapy/ Infrared Therapy Products), By Distribution Channel, And Segment Forecasts, 2023 - 2030 |
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 67¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç ¿¹Ãø ±â°£ Áß CAGRÀº 13.3%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ÀÔ¿øÀϼö ´ÜÃà¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹Ì±¹³» ±â¼ú ¹ßÀüÀÌ ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
¹Ì±¹¿¡¼´Â ÇコÄÉ¾î »ê¾÷À» Çü¼ºÇÏ´Â ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÀÔ¿ø ±â°£ ´ÜÃà¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â º´¿ø°ú ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ÀÚ¿ø Ȱ¿ëÀ» ÃÖÀûÈÇÏ°í ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥, ºñ¿ë Àý°¨¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Àå±â ÀÔ¿øÀº ÀÇ·á ºñ¿ëÀ» Áõ°¡½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ¸¦ ÇÕº´Áõ°ú °¨¿°ÀÇ À§Çè¿¡ ³ëÃâ½Ãų ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ ƯÁ¤ Ä¡·á¿Í ¼ºñ½º¸¦ °¡´ÉÇÑ ÇÑ ÀÔ¿ø½Ç¿¡¼ ¿Ü·¡·Î ¿Å±â´Â °Í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ ÀÔ¿ø Àϼö ´ÜÃà¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡°¡ ¿¹Ãø ±â°£ Áß ÅëÁõ °ü¸® ±â±â ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ValuePenguinÀÇ 2022³â ¹ßÇ¥¿¡ µû¸£¸é ¹Ì±¹ º´¿øÀÇ Æò±Õ ÀÔ¿ø ±â°£Àº ¾à 4.6ÀÏÀ̸ç, 1ÀÏ´ç Æò±Õ ºñ¿ëÀº 2,873´Þ·¯(USD)¿¡ ´ÞÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ³ôÀº ÀÔ¿ø ºñ¿ëÀ¸·Î ÀÎÇØ ÀÔ¿ø ±â°£ ´ÜÃà°ú ºñ¿ë È¿À²ÀûÀÎ Ä¡·á ȯ°æÀ¸·ÎÀÇ ÀüȯÀÌ ÇÊ¿äÇϸç, ÅëÁõ °ü¸® ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
±â¼úÀÇ ¹ßÀüÀº ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå »óȲ¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, ÅëÁõ °ü¸®¸¦ À§ÇÑ »õ·Ó°í Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¿Ü¿ë ÁøÅëÁ¦ÀÇ °³¹ß, ó¹æ ¹× Åõ¿© ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ À¯È¿¼º, ÆíÀǼº ¹× ȯÀÚ °á°ú °³¼±À¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù.
COVID-19 Àü¿°º´Àº ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀåÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ »ê¾÷¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ´ÙÀ½Àº Àü¿°º´ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¿äÁ¡ÀÌ´Ù: COVID-19 ÆÒµ¥¹ÍÀ¸·Î ¹Ì±¹¿¡¼ ¿Ü¿ë ÁøÅëÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ÀÌ´Â Áý¿¡¼ Ä¡·áÇÏ´Â ¹æ¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡Çß°í, ¹®À» ´Ý°í ÀÚ°¡°Ý¸®ÇÏ´Â µî ÀÚ°¡ °ü¸®ÀÇ ½ÇõÀÌ Áõ°¡Ç߱⠶§¹®ÀÔ´Ï´Ù.
The U.S. external analgesics market size is expected to reach USD 6.7 billion by 2030, exhibiting a CAGR of 13.3% during the forecast period according to a new report by Grand View Research, Inc. Increasing incidence of chronic illness, increased demand for reduced hospital stays, and rising technological advancement in the country are driving the growth of external analgesics market in U.S.
The demand for reduced hospital stays is increasing in the U.S. due to various factors shaping the healthcare industry. One significant driver is the growing emphasis on cost containment, which is compelling hospitals and healthcare providers to optimize resource utilization and reduce expenses. Prolonged hospital stays not only increase healthcare costs but also expose patients to a higher risk of complications and infections. Consequently, there is a growing focus on shifting certain treatments and services from inpatient to outpatient settings whenever possible.
This growing demand for shorter hospital stays is expected to drive the market for pain management devices over the forecast period. The average length of stay in U.S. hospitals is approximately 4.6 days, with each day costing an average of USD 2,873, as per a 2022 article published by ValuePenguin. The high costs of hospitalization have amplified the need for shorter stays and a shift toward more cost-effective care settings, leading to an increased demand for pain management devices.
Technological advancements have significantly influenced the landscape of the U.S. external analgesics market, bringing about new and innovative solutions for pain management. These advancements have revolutionized the way external analgesics are developed, formulated, and administered, leading to improved effectiveness, convenience, and patient outcomes.
The COVID-19 pandemic has had a significant impact on various industries, including the U.S. external analgesics market. Here are some key points regarding the influence of the pandemic on the market: The COVID-19 pandemic has led to a surge in demand for external analgesics in the U.S. This can be attributed to factors such as the rise in the adoption of home-based remedies and self-care practices during lockdowns and restrictions.